Applications

Life Sciences

How Bruker’s unique analytical methods and technological systems drive innovation in the fast growing fields of Life Science such as Genomics, Proteomics and Metabolomics.

Helping People to Lead Better Lives

Life science is changing rapidly and constantly. New discoveries lead to more efficient and faster development of innovative molecular research methods as well as small and large molecular therapeutics – thus creating a basis for sustainable growth in these markets. With innovative solutions Bruker supports pharmaceutical companies, research institutes and development organizations in driving therapeutical advancements, managing costs, expanding analytical capabilities and significantly increasing productivity.

Choose Your Area of Interest

Cell-and-molecular-biology

Cell and Molecular Biology

The demand for novel techniques that enable the investigation of biological samples has led to exciting new developments. State-of-the-art techniques enable the investigation of the morphology and surface structure of cells, cell membranes and their cytoskeleton structures, down to individual biomolecules, nucleic acids and proteins at submolecular resolution.

Life Science Reserach Imaging

Imaging

Imaging plays a crucial role in understanding how the body works in both healthy and disease states and describing responses to physiological or environmental change. It provides important insights into disease mechanisms at organ, tissue, cell, and molecular levels.

Metabolomics

Metabolomics aims at a comprehensive qualitative and quantitative analysis of all small molecules present in a cell a tissue or an organism to study the interplay in response to intrinsic and extrinsic factors.

Neuroscience

Neuroscience involves the study of neurological disorders and encompasses a wide array of modalities to study the pathology and function of the brain. Our PET/MR instruments allow scientists to address more complicated questions, which are key to understanding a range of debilitating conditions.

Oncology

Non-invasive imaging provides key insights into tumor development, response to treatment and drug toxicity. The analytical value of individual imaging strategies can be further enhanced by combining structural and functional imaging modalities. Multimodal imaging in preclinical research using in vivo imaging allows cancer-related processes to be visualized in real time with high sensitivity and resolution. A deeper understanding of a range of tumors and improve treatment options have been obtained through the use of a variety of imaging techniques, including MRI, SPECT, PET and CT, and microCT.

Pneumology

Imaging methods have helped researchers determine the precise nature of the underlying causes of many lung disorders, which has significantly improved pneumology diagnoses. Preclinical small animal imaging, in particular, has provided valuable insights into the mechanisms of lung disease and the effects of treatment.

Proteomics

Learn how Bruker's customized and advanced analytical solutions in proteomics help identify potential new drugs for successful treatment and diagnosis.

Structural Biology

Structural Biology

Establishing high resolution structural models of macromolecules, measuring distances in biologically active macromolecular structures, and following conformational changes are widely complementary tasks which finally enable you to build the complete biological picture. Bruker’s solutions are designed to measure data fast, reliable and are easy to use. Bruker provides the tools to convert data into information, information into knowledge and knowledge into understanding.

Software_PCI_pmod2

Cardiology

By imaging animal models of cardiovascular diseases with Magnetic resonance imaging researchers can gain a better understanding of disease pathophysiology and progression with the hope of discovering novel therapeutic targets.

For Research Use Only. Not for use in clinical diagnostic procedures.